SDSteven Denyer

Steven Denyer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Steven Denyer has a total of 76 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Patellar tracking and patellar tilt in kinematic versus mechanical knees

    by Meredith Benson, Chase Gornbein, Mitchell Pfennig, Steven Denyer, Nicholas Brown

    Purpose: This study aims to compare patellar tracking and tilt following kinematic and mechanical total knee arthroplasty (TKA) via comparison of the incidence of lateral release and the patellar tilt angle on the postoperative sunrise X‐ray view. Methods: A retrospective study was conducted identifying 252 patients who underwent TKA. Radiographic measurements were collected prior to and following TKA, including the mechanical distal femoral angle, proximal tibial angle, lateral joint line release, patellar tilt and patellar displacement prior to and following operation. Results: Of the 222 patients analysed, 119 patients underwent kinematic TKA (KA‐TKA) and 103 patients underwent mechanical TKA (MA‐TKA). Mechanically aligned knees were found to have a higher incidence of lateral joint line release (3.9% vs. 0%) ( p = 0.04) and a greater incidence of patellar retinacular release (4.9% vs. 0.8%), although not significant ( p = 0.10). There was no difference between kinematic and mechanical TKA regarding change in patellar tilt or patellar displacement prior to and following TKA. Conclusion: Patellar tracking was found to be comparable between mechanical and kinematic TKA, with no significant difference in incidence of patellar release, patellar tilt or patellar displacement. Mechanically aligned TKA required a non‐statistically significant increased incidence of lateral joint line release. Overall, these results support that MA‐TKA and KA‐TKA both result in satisfactory patellar tracking with possible reduced need for patellar and lateral joint line releases in KA‐TKA. Level of Evidence: Level III, clinical research.

  • Open Access

    Results of Aspiration, Erythrocyte Sedimentation Rate, and C-Reactive Protein in Patients With Known Prosthetic Joint Infection on Chronic Suppression

    by Meredith Benson, Steven Denyer, Amy Wozniak, Daniel Schmitt, Nicholas Brown

    Introduction: Chronic antibiotic suppression (CAS) is regarded as a reasonable treatment option for persistent prosthetic joint infection in patients with multiple failed surgical eradication attempts or comorbidities that preclude surgical treatment. However, patient response to CAS has been highly variable. The purpose of this study is to determine if inflammatory marker values predict success with CAS and assess average inflammatory marker values to facilitate more accurate periprosthetic joint infection (PJI) diagnoses in patients suspected of having prosthetic joint infection who were already started on antibiotics. Methods: A retrospective cohort study was conducted, identifying 46 patients on CAS. Inclusion based on culture-proven PJI and treatment with chronic suppressive antibiotics. Failure was defined as requirement of revision surgery or death related to PJI. Laboratory values (erythrocyte sedimentation rate [ESR], C-reactive protein [CRP], polymorphonuclear neutrophilic [PMN] leukocyte, synovial white blood cell [WBC]) within 2 years following suppression initiation were collected. Wilcoxon rank-sum tests were used to compare laboratory values between those with success and failure. Results: This study analyzed 33 total knee and 16 total hip arthroplasties. The strongest predictor of failure with CAS within 2 years of treatment was elevated ESR (P < 0.05). Despite antibiotic treatment, 0 to 2 years following CAS initiation, 75% of patients had an elevated PMN% and 83.3% had elevated synovial WBC. CRP remained elevated in only 39.3% of patients, and ESR remained elevated in 66.7% of patients. Conclusion: The primary laboratory predictor of those who failed with CAS was elevated ESR. Second, elevated PMN% and synovial WBC were determined to be the strongest indicators of PJI in a patient who was treated with antibiotics before diagnosis, although CRP and ESR were more likely to normalize. This suggests that patients with strong clinical suspicion for PJI on antibiotics should be aspirated regardless of normalized ESR and CRP.


  • Open Access

    Effect of Preoperative Corticosteroids on Postoperative Glucose Control in Total Joint Arthroplasty

    by Steven Denyer, Abhishek Ramini, Carlo Eikani, Michael P. Murphy, Nicholas Brown


  • Open Access

    Diagnosing periprosthetic joint infection

    by Steven Denyer, Carlo Eikani, Monica Sheth, Daniel Schmitt, Nicholas Brown

    Diagnosing periprosthetic joint infection


  • Open Access

    Knee Arthrodesis: An Analysis of Surgical Risk Factors and Complications Using a National Database

    by Steven Denyer, Aaron K. Hoyt, Andrew M. Schneider, Nicholas M. Brown


  • Cost Analysis of Conversion Total Knee Arthroplasty

    by Steven Denyer, Carlo Eikani, Daniel Bujnowski, Hassan Farooq, Nicholas Brown

    Background: Total knee arthroplasty (TKA) after prior knee surgery, also known as conversion TKA (convTKA), has been associated with higher complications, resource utilization, time, and effort. The increased surgical complexity of convTKA may not be reflected by the relative value units (RVUs) assigned under the current U.S. coding guidelines. The purpose of this study was to compare the RVUs of primary TKA and convTKA and to calculate the RVU per minute to account for work effort. Methods: The American College of Surgeons National Surgical Quality Improvement Project (NSQIP) database was analyzed for the years 2005 to 2020. Current Procedural Terminology (CPT) code 27447 alone was used to identify patients who underwent primary TKA, and 27447 plus 20680 were used to identify convTKA. After 1:1 propensity score matching, 1,600 cases were assigned to each cohort. The 2023 Medicare Physician Fee Schedule RVU-to-dollar conversion factor from the U.S. Centers for Medicare & Medicaid Services (CMS) was used to calculate RVU dollar valuations per operative time. Complication rates were compared using a multivariate logistic regression model controlling for baseline characteristics. Results: The mean operative time for TKA was 97.8 minutes, with a corresponding RVU per minute of 0.25, while the mean operative time for convTKA was 124.3 minutes, with an RVU per minute of 0.19 (p < 0.0001). Using the conversion factor of $33.06 per RVU, this equated to $8.11 per minute for TKA versus $6.39 per minute for convTKA. ConvTKA was associated with higher overall complication (10.9% versus 6.5%, p < 0.0001), blood transfusion (6.6% versus 3.7%, p < 0.01), reoperation (2.3% versus 0.94%, p < 0.0001), and readmission (3.7% versus 1.8%, p < 0.001) rates. Conclusions: The current billing guidelines lead to lower compensation for convTKA despite its increased complexity. The longer operative time, higher complication rate, and increased resource utilization may incentivize providers to avoid performing this operation. CPT code revaluation is warranted to reflect the time and effort associated with this procedure. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.


  • Differentiation of Outcomes by Treatment Regimen and Histology in Central Nervous System Primary Embryonal Tumors

    by Abhiraj D. Bhimani, James S. Ryoo, Abhinav K. Reddy, Steven Denyer, Laura S. McGuire, Matthew Alonso, Ankit I. Mehta


  • Adult Spinal Arteriovenous Malformations: Natural History and a Multicenter Study of Short-Term Surgical Outcomes

    by Abhiraj D. Bhimani, Clayton L. Rosinski, Saavan Patel, Nauman S. Chaudhry, Steven Denyer, Mandana Behbahani, Ankit I. Mehta


  • Primary Malignant Melanoma of the Brain: A Population-Based Study

    by Carolina Puyana, Steven Denyer, Taylor Burch, Abhiraj D. Bhimani, Laura S. McGuire, Akash S. Patel, Ankit I. Mehta


  • Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis

    by Abhinav K. Reddy, James S. Ryoo, Steven Denyer, Laura S. McGuire, Ankit I. Mehta

    OBJECTIVE: The aim of this study was to illustrate the demographic characteristics of meningioma patients and observe the effect of adjuvant radiation therapy on survival by using the Surveillance, Epidemiology, and End Results (SEER) database. More specifically, the authors aimed to answer the question of whether adjuvant radiotherapy following resection of atypical meningioma confers a cause-specific survival benefit. Additionally, they attempted to add to previous characterizations of the epidemiology of primary meningiomas and assess the effectiveness of the standard of care for benign and anaplastic meningiomas. They also sought to characterize the efficacy of various treatment options in atypical and anaplastic meningiomas separately since nearly all other analyses have grouped these two together despite varying treatment regimens for these behavior categories. METHODS: SEER data from 1973 to 2015 were queried using appropriate ICD-O-3 codes for benign, atypical, and anaplastic meningiomas. Patient demographics, tumor characteristics, and treatment choices were analyzed. The effects of treatment were examined using a multivariate Cox proportional hazards model and Kaplan-Meier survival analysis. RESULTS: A total of 57,998 patients were included in the analysis of demographic, meningioma, and treatment characteristics. Among this population, cases of unspecified WHO tumor grade were excluded in the multivariate analysis, leaving a total of 12,931 patients to examine outcomes among treatment paradigms. In benign meningiomas, gross-total resection (HR 0.289, p = 0.013) imparted a significant cause-specific survival benefit over no treatment. In anaplastic meningioma cases, adjuvant radiotherapy imparted a significant survival benefit following both subtotal (HR 0.089, p = 0.018) and gross-total (HR 0.162, p = 0.002) resection as compared to gross-total resection alone. In atypical tumors, gross-total resection plus radiotherapy did not significantly change the hazard risk (HR 1.353, p = 0.628) compared to gross-total resection alone. Similarly, it was found that adjuvant radiation did not significantly benefit survival after a subtotal resection (HR 1.440, p = 0.644). CONCLUSIONS: The results of this study demonstrate that the role of adjuvant radiotherapy, especially after the resection of atypical meningioma, remains somewhat unclear. Thus, given these results, prospective randomized clinical studies are warranted to provide clear information on the effects of adjuvant radiation in meningioma treatment.